Company Profile
Updated: 28-OCT-09Lonza Group AG
International public company
Muenchensteinerstrasse 38, Basel, CH-4002, Switzerland
()41 061 316 83 61, 41 061 316 91 11 fax, http://www.lonza.com
Primary SIC: Industrial Organic Chemicals, Not Elsewhere Classified, Primary NAICS: All Other Inorganic Chemical Manufacturing
Description: Manufacturing: Lonza Group is one of the world's leading specialty chemical and biotechnology companies, focused on fine chemicals for the life science industry. The company develops, manufactures and sells a wide range of complex value-added organic fine chemicals with applications in pharmaceuticals, agrochemicals, vitamins, food and feedstuffs, dyes and pigments, adhesives and fragrances. Lonza Group is the world leader in exclusive custom manufacturing of active ingredients and substances for life science companies and at the forefront of developments in the biotech field. The performance chemicals business is focused mainly on microbiologically active substances known as biocides. The intermediates and additives business is centred on the manufacture of key chemical building blocks such as phtahlic, maleic, trimellitic anhydride and isophtalic acid, using proprietary catalysts and technologies and their derivatives such as plasticisers, unsaturated polyester resins and technocompounds
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 11/3/2009; 2228 words; ...Calif., and Lonza Group Ltd., of Basel, Switzerland...evolution platform, which Lonza will use for the commercial...materials produced in bulk by Lonza. Each enzyme has been...fees and royalties from Lonza, and will sell commercial...agreement with Syngenta AG, of Basel, ...
MZ Comments on the Use of Interactive Share Price Graphs.
Biotech Week; 9/30/2009; 944 words; ...Global Bio-chem Technology Group (HKSE: 0809); Global Sources...HYSNY.PK); Integrys Energy Group (NYSE:TEG); Intel (NASDAQ...Technologies (NYSE:LFT); Lonza (SIX: LONN); METRO (FSE...Software, Technology, Novartis AG, Pharmaceutical Business...
Swiss Lonza, Canadian Patheon extend due diligence period.
ADP News Switzerland; 9/28/2009; 494 words; ...chemical and biotechnology company Lonza Group AG (SIX:LONN) and Canadian pharmaceuticals...allow continued discussions regarding Lonza's proposal to acquire all of Patheon...3.55 (EUR 2.43) per share, Lonza said. The two companies consider...
JLL Reiterates Rejection of Lonza Group AG's Non-Binding Acquisition Proposal for Patheon Inc.; JLL Views Lonza Proposal as Hostile Attempt to Harm Patheon Through Inappropriate Access to Patheon Confidential Information.
Mergers & Acquisitions Week; 9/9/2009; 962 words; ...rejected the non-binding proposal by Lonza Group AG (SIXX: LONN) to acquire all of...Patheon Inc. (TSX: PTI) (the "Lonza Proposal"). By press release issued...separate letters and phone calls to Lonza's Supervisory Board of Directors...
The Daily Record Business News Briefs: September 4, 2009
The Daily Record (Baltimore); 9/4/2009; 996 words; ...ruling that the Nutrinova unit of Switzerland-based Lonza Group AG infringed two of its patents. The U.S. Court of Appeals...that patent to be invalid. The lower court prohibited Lonza, the world's largest maker of drug ingredients, from...
Recent News Articles
- JLL Reiterates Rejection of Lonza Group AG's Non-Binding Acquisition Proposal for Patheon Inc.; JLL Views Lonza Proposal as Hostile Attempt to Harm Patheon Through Inappropriate Access to Patheon Confidential Information.
Mergers & Acquisitions Week - September 09, 2009 - JLL Reiterates Rejection of Lonza Group AG's Non-Binding Acquisition Proposal for Patheon Inc.; JLL Views Lonza Proposal as Hostile Attempt to Harm Patheon Through Inappropriate Access to Patheon Confidential Information.
PR Newswire - August 27, 2009 - JLL Rejects Non-Binding Acquisition Proposal From Lonza Group AG.
PR Newswire - August 21, 2009 - SINGAPORE: Joint venture construction start-up on planned active pharmaceutical ingredients plant is tentatively scheduled to begin by the end of 2005, BIOCAPITAL LTD. [Singapore] & LONZA GROUP AG [Switzerland] Order #: 092405.
WWP-Report on Engineering Construct & Plant Operations in the Developing World - September 20, 2005
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
Related Company Profiles
- E Raoul-Duval et Cie S.A.
- International Flavors and Fragrances Inc.
- Clariant LSM Inc. (Gainesville, Florida)
